Otsuka Pharmaceutical Companies (U.S.)

Earlier this summer, we were humbled to be part of the first annual Stop Stigma Together (SST) summit to end the stigma against mental illness and substance use disorder. As part of our participation, we had the opportunity to share the findings from ‘The Projected Cost and Economic Impact of Mental Health Inequities in the United States report,’ authored by national expert Daniel Dawes, Dean of the Meharry School of Global Health with fellow attendees. Through our commitment to health for every mind, we will continue to emphasize that the mental health crisis in the United States should be treated as an emergency, encompassing a cross-sector approach. To read the full report: https://bit.ly/4dybF30 Otsuka is proud to be a lead, founding sponsor of 'The Projected Cost and Economic Impact of Mental Health Inequities in the United States Report.’

This National Intern Day, we would like to thank all our InTOW interns for such a dynamic summer with us. Our 50+ interns continuously live by our purpose: defy limitation, so that others can too.   Their motivated work, innovative thinking, and resourceful creativity are unparalleled, as they demonstrate what it truly means to be an Otsuka-person.  As we come to the close of our program in the next couple of weeks, we wish all of them good luck on their journey ahead!   #NationalInternDay #DefyLimitation

Did you know that 43% of caregivers sacrifice their mental well-being due to their responsibilities as an Alzheimer’s disease or dementia family caregiver? At Otsuka, we’re working to lead an industry-wide shift in the ways caregivers are valued and supported. We are dedicated to caring for caregivers—standing with them, the way they stand with their loved ones—and offering the tools they need for the health of others and themselves. Our newly released fridge magnet provides caregivers with a moment to stop and process their feelings, and the many layers of emotions that come with providing this support for a loved one. If you're a family caregiver, how are you feeling today? For more information on our commitment to caregivers: https://lnkd.in/g4dtSda4

We are grateful to continue our work with Missy Franklin to raise awareness of autosomal dominant polycystic kidney disease (ADPKD), a rare genetic condition that causes cysts to form on the kidneys, eventually leading to a decline in kidney function and requiring a need for dialysis or a transplant.   For more than 20 years, Otsuka has brought new research and expertise to the #nephrology space. Our long-term perseverance has led to significant breakthroughs, giving patients renewed hope and clinicians more options.   Watch Missy speak of her family's journey with ADPKD on CBS Mornings. Missy Franklin is a paid collaborator of Otsuka America Pharmaceutical, Inc.

"There is still much work to be done so that each person, regardless of race, gender, or socioeconomic background, can benefit from equitable access to care." Debra Barrett, Vice President, Corporate Affairs Join us on Wednesday, July 24, at 8:30 a.m. EDT for Mind the Gap: The Cost of Mental Health Disparities, a live discussion hosted by The Hill and sponsored by Otsuka America Pharmaceutical, Inc. In honor of Minority Mental Health Awareness Month, the Hill will bring together lawmakers, mental health experts and advocates to discuss these questions and more as they discuss the findings of the Meharry School of Global Health's 2024 study, “The Projected Costs and Economic Impact of Mental Health Inequities in the United States.” Register for the event: https://bit.ly/3zwBf98 Otsuka is proud to be a lead, founding sponsor of 'The Projected Cost and Economic Impact of Mental Health Inequities in the United States Report.’

We recognize all those who live with a brain illness or disease and remain dedicated to uplifting and sharing brain health stories as well as promoting educational resources and prevention.      At Otsuka, we hold a deep respect for the value of every mind. As we work each and every day to demonstrate our commitment to health for every mind – for patients, caregivers, and other members of the community, we put equal emphasis on nurturing and honoring the value of your mind.     Learn more about our mission: https://bit.ly/3VHejLS   #WorldBrainDay #BrainAwareness

We are honored to announce our placement as #14 on 2024 Fortune Best Workplaces in New York™ List and #72 on 2024 Fortune Best Workplaces for Millennials™ List.     Otsuka Pharmaceutical Companies (U.S.) is a dynamic organization made up of motivated individuals—people who have a shared mission for creating new products for better health worldwide.   We live by our purpose: defy limitation, so that others can too. This purpose motivates and drives us each day for all those we serve.    Learn more about our culture now: https://bit.ly/3WkBPQn    #DefyLimitation

In celebration with National Disability Pride Month, Otsuka has been recognized by Disability:IN as a “Best Place to Work for Disability Inclusion in the United States” for the third year. At Otsuka, we are committed to supporting Otsuka-people with visible and invisible disabilities, offering a range of benefits to our employees, including: - Family & Medical Leave - Request of ADA Medical Accommodation - Ergonomic Assessment - Caregiver Benefits - Lyra We will continue to prioritize the needs and well-being of Otsuka-people, ensuring that all have access to the resources and support they need to succeed in the workplace. Learn more about the heart of our mission: https://bit.ly/3LxiGW9 #DisabilityEqualityIndex #BestPlacestoWork

Since 988’s founding, the lifeline has received over 23 million calls and has become synonymous with help in times of crisis, with hopes to continue reaching and providing support to all in need and with emotional distress. In May 2024 alone, a total of 485,955 calls, chats, and texts were answered.    At Otsuka, we hold a deep respect for the value of every mind and are committed to uplifting resources, such as 988, that recognize mental illnesses and brain conditions as chronic diseases that warrant early, equitable, and accessible intervention.      Discover our commitment to health for every mind: https://bit.ly/4cB7LF8

At this year's annual NAMICon (NAMI), we were delighted to be on-the-ground, not only connecting with fellow mental health advocates and organizations, but to continue showcasing our work with the Meharry School of Global Health and the newly released 'The Projected Cost and Economic Impact of Mental Health Inequities in the United States Report.’ In the captivating speaker session, hosted by Nelson Dunlap, Vice President, Public Policy & External Affairs of Meharry School of Global Health, he covered the ground-breaking research of the 2022 Economic Burden of Mental Health Inequities in the US report and discussed the significant findings of the newly released 2023 report: - The United States currently spends significant dollars on avoidable and unnecessary expenses related to mental health inequities, yet there is still a siloed system where individuals struggle to access the care they need. - By 2040, the cumulative cost of untreated mental health conditions to the US economy is estimated to amount to $14 trillion – we must act now. - The mental health crisis in the United States should be treated as an emergency requiring a cross-sector approach to improve patient outcomes.   Read the full report now: https://bit.ly/4dybF30 Discover Otsuka’s commitment to health for every mind: https://lnkd.in/g9XJxmzr Otsuka is proud to be a lead, founding sponsor of 'The Projected Cost and Economic Impact of Mental Health Inequities in the United States Report.’